Saturday 17 October 2026 Export ACAD’s income statement to Excel — free account

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 11.9% from fiscal 2024. In the quarter to June 2026, revenue grew 16.4%, EPS grew 12.5% and free cash flow grew 50.3%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

19.12 0.59 −2.99%

Follow ACAD

Alert me

Market cap: $3.4B
P/E: 8.5×
Fwd P/E: 55.6×
Dividend yield: —
F-score: 6/9
Altman Z: 7.90
Beneish M: −0.89
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	11.24	9.98	11.51	13.68	+8 more quarters Free account
P/S ratio Full definition →	3.81	3.47	4.20	3.44
P/FCF ratio Full definition →	0.00	0.00	0.00	56,296.25
P/Operating CF Full definition →	43.08	111.70	(92.28)	48.50
P/B ratio Full definition →	3.32	3.04	3.66	3.93
Price to Tangible BV Full definition →	3.61	3.32	4.02	4.47
EV/Sales Full definition →	2.97	2.69	3.43	2.63
EV/EBITDA Full definition →	35.22	33.10	33.08	11.14
EV/Operating CF Full definition →	21.12	23.84	33.48	13.85
EV/FCF Full definition →	(65.04)	(35.02)	(39.55)	43,064.04
Quick Ratio Full definition →	3.11	3.27	3.49	2.77
Current Ratio Full definition →	3.39	3.59	3.83	3.02
Net Debt/EBITDA Full definition →	(23.36)	410.14	(41.72)	(22.52)
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.77	0.80	0.78	0.91
Operating CF/Net income Full definition →	3.20	9.34	(0.18)	1.04
Capex/Depreciation Full definition →	(1.64)	(2.05)	(1.78)	(53.69)
Research and Development Expense of Revenue Full definition →	26.48%	28.68%	29.85%	31.52%
Selling, General and Administrative Expense of Revenue Full definition →	52.04%	63.80%	54.80%	47.88%
Intangible Assets out of Total Assets Full definition →	0.06	0.07	0.07	0.08
Share Based Compensation of Revenue Full definition →	5.50%	5.48%	4.66%	4.73%
Graham Net Nets Full definition →	0.18	0.19	0.16	0.18
Graham Number Full definition →	19.63	19.16	19.51	13.81
Earnings Yield Full definition →	8.89%	10.02%	8.69%	7.31%
Free Cash Flow Yield Full definition →	(1.20%)	(2.22%)	(2.07%)	0.00%
Revenue per Share Full definition →	1.79	1.57	1.69	1.65
Operating CF per Share Full definition →	0.59	0.20	(0.29)	0.44
Capex per Share Full definition →	(0.03)	(0.03)	(0.02)	(0.59)
Free Cash Flow per Share Full definition →	0.56	0.17	(0.31)	(0.15)
Cash per Share Full definition →	5.57	4.99	4.87	5.02
Shareholders Equity per Share Full definition →	7.61	7.32	7.29	5.43
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	7.61	7.32	7.29	5.43
Free Cash Flow Full definition →	95.69	28.77	(52.74)	(24.94)
Working Capital Full definition →	863.11	790.49	785.00	719.84
Capital Expenditures Full definition →	(5.09)	(5.21)	(4.00)	(99.23)
Net Current Asset Value Full definition →	788.25	738.85	725.31	662.92
EV/EBIT Full definition →	39.20	36.39	35.08	11.44
Capex to Sales Full definition →	0.02	0.02	0.01	0.36
Price to Operating Income Full definition →	50.27	46.92	42.90	14.95
Other line items
Average Receivables Full definition →	143.01	131.05	126.46	124.90
Average Payables Full definition →	32.33	15.17	13.55	20.41
Average Inventory Full definition →	29.25	27.26	28.31	45.07
Average Assets Full definition →	1,484.23	1,368.80	1,375.98	1,153.82
Average Common Equity Full definition →	1,064.50	1,006.65	980.09	747.23

Fold the line items

Columns are period end dates

Stockrow Weekly